Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Pro-Israel Dem says those who won’t decry Hamas over Oct. 7 attack ‘have no business’ posing as humanitarians

by admin July 24, 2025
July 24, 2025
Pro-Israel Dem says those who won’t decry Hamas over Oct. 7 attack ‘have no business’ posing as humanitarians

Rep. Ritchie Torres, D-N.Y., an outspoken opponent of antisemitism, said Wednesday that those who refuse to speak out against the heinous acts Hamas perpetrated in Israel on Oct. 7, 2023 ‘have no business’ claiming to be humanitarians.

‘If you refuse to condemn Hamas for the murder, maiming, mutilation, rape, torture, and abduction of thousands of Jews and Israelis on October 7, then you have no business calling yourself a humanitarian,’ Torres wrote on X. 

‘A humanitarianism that devalues Jewish life is no humanitarianism at all, for it has been hollowed out by antisemitism,’ he added.

The congressman has been a strong voice of support for Israel.

‘The singular stumbling block to ending the war is the terrorist organization that barbarically began it: Hamas. Scapegoating Israel is so second nature to the international community that Hamas’ role in precipitating and perpetuating the war has been all but forgotten,’ Torres wrote on X earlier this month.

In another post on X this month he opined that ‘Antisemitism is the deadliest disease ever to afflict the human heart.’

In a post last month, he asserted, ‘If Israel is the sole country in the Middle East—indeed the world—for which you reserve the label ‘apartheid’—then your use of the term is probably propagandistic rather than principled and your purpose is not constructive criticism but the destructive delegitimation of Israel as a Jewish State.’

Torres has served in the U.S. House of Representatives since early 2021.

This post appeared first on FOX NEWS

previous post
5 Best-performing Canadian Oil and Gas Stocks of 2025
next post
UnitedHealth says it faces DOJ investigation over Medicare billing practices

Related Posts

What did Obama know about the Trump–Russia probe?...

August 29, 2025

Vance defends Gabbard as ‘critical part’ of Trump...

June 19, 2025

Which countries impose the highest tariffs on the...

April 3, 2025

Trump touts Kim Jong Un relationship amid South...

August 26, 2025

Jeffrey Epstein case reopens focus on Ghislaine Maxwell...

July 23, 2025

HHS axes more than $300M in gender, DEI-related...

March 28, 2025

Trump-backed bill to stop ‘rogue’ judges passes House

April 10, 2025

After Charlie Kirk, America is awash in a...

September 18, 2025

Trump shares post saying Biden was executed, replaced...

June 2, 2025

King Charles III visits Canada as show of...

May 27, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved